Health · 3 views
Abdakibart Shows Strong Early Efficacy in Hidradenitis Suppurativa
(MedPage Today) -- Phase II findings presented at the European Academy of Dermatology and Venereology meeting in Vienna showed promising early efficacy with abdakibart, an investigational interleukin (IL)-1 beta inhibitor, in patients…
Summary
(MedPage Today) -- Phase II findings presented at the European Academy of Dermatology and Venereology meeting in Vienna showed promising early efficacy with abdakibart, an investigational interleukin (IL)-1 beta inhibitor, in patients with hidradenitis
AI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedMore from Health
Continue reading recent Health coverage
- It was a big night for doctors to win seats in Congress, riding the blue waveContinue reading
- Some 1,800 dead from cholera in Ebola-hit DR Congo: WHOContinue reading
- Democrats’ Election Rout Is Poised To Dramatically Reorder Federal Health PolicyContinue reading
- WHO sounds alarm over lack of physical activity among teensContinue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow